EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies

Shruti Shetty, Naveena A N Kumar, Shama Prasada Kabekkodu, Sanjiban Chakrabarty

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189627

DOI: 10.1016/j.bbcan.2026.189627 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Shruti Shetty und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Drug Discovery, Lab-On-A-Chip Devices, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research, Manipal Academy of Higher Education, Technology Information, Forecasting and Assessment Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microfluidic organ-on-chip (OoC) technologies have emerged as reliable platforms for the physiologically accurate simulation of human tumours by precisely modulating cellular, biochemical, and biomechanical parameters. This review critically examines recent advancements in organ-on-chip (OoC) systems for applications in precision oncology, immuno-oncology, preclinical drug discovery, therapeutic response assessment, and mechanistic studies of therapeutic resistance. Unlike traditional preclinical models, OoC systems integrate patient-derived tumour tissues, stromal and immunological components, and three-dimensional microenvironments to more accurately reflect tumour heterogeneity and therapeutic response. We further explored how these technologies enable the real-time evaluation of drug sensitivity, immunological interactions, hypoxia-driven adaptability, and stroma-mediated resistance, providing functional insights beyond genetic profiling. By incorporating recent developments in patient-derived models, immunooncology, mechanobiology, and clinically relevant drug response prediction, this review underscores the translational and mechanistic significance of OoC technologies, distinguishing it from previous reviews that primarily focused on microfabrication and device engineering. We also address contemporary challenges related to standardisation, regulatory validation, scalability, and reproducibility. Collectively, OoC technologies hold significant potential to advance precision medicine, enhance translational oncology, and reduce reliance on animal models in cancer research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryLab-On-A-Chip DevicesNeoplasmsAntineoplastic AgentsMicrofluidicsHumansAnimalsMicrophysiological SystemsTumor MicroenvironmentDrug Evaluation, PreclinicalPrecision Medicine

Stichwörter der Autor:innen

Drug developmentOrgan-on-ChipPersonalised medicinePreclinical studiesTumour microenvironmentcancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
  • Department of Surgical Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
  • Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
  • Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India. Electronic address: sanjiban.c@manipal.edu.

Förderung

  • Indian Council of Medical Research
  • Manipal Academy of Higher Education
  • Technology Information, Forecasting and Assessment Council
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Shetty, S., Kumar, N. A. N., Kabekkodu, S. P., & Chakrabarty, S. (2026). A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189627. https://doi.org/10.1016/j.bbcan.2026.189627

Vancouver

Shetty S, Kumar NAN, Kabekkodu SP, Chakrabarty S. A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189627. doi:10.1016/j.bbcan.2026.189627

BibTeX
@article{Shetty2026,
  author = {Shetty, Shruti and Kumar, Naveena A N and Kabekkodu, Shama Prasada and Chakrabarty, Sanjiban},
  title = {A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {4},
  pages = {189627},
  doi = {10.1016/j.bbcan.2026.189627}
}
Kostenlos starten →